SCHEMBL22017043

SCHEMBL22017043

CC(C)[C@H](N)C(=O)OCC[C@H](NC(=O)[C@@H]1SCCN1S(=O)(=O)Cc1ccc(-c2ccccc2)cc1)c1ccc(F)cc1

nearest known ligand 0.81

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGFR P43088 1/20 0.81
FKBP1A P62942 2/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CCR5 P51681 2/20 0.34
DPP4 P27487 4/20 0.33
DPP7 Q9UHL4 4/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
DPP8 Q6V1X1 3/20 0.33
KCNH2 Q12809 2/20 0.33
DPP9 Q86TI2 2/20 0.33
KDM1A O60341 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ebopiprant SCHEMBL26496347 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL26667891 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL18055682 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL19077960 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL21142449 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL24797015 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL18055678 0.90 PTGFR (1.00) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL18055681 0.89 PTGFR (0.98) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL18055684 0.89 PTGFR (0.98) PTGFRLMNAALDH1A1MAPT
Ebopiprant SCHEMBL26667889 0.89 PTGFR (0.98) PTGFRLMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524003-B2 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof ObsEva S.A. (CH) 2022-12-13 US disclosed
US-20200155515-A1 ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF XOMA (US) LLC 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155515-A1 ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF PGF, PTGER1, PTGER4 PTGFR 6/4885FKBP1A 973/4885MEN1 4822/4885
US-11524003-B2 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof PGF, PTGER1, PTGER4 PTGFR 6/4885FKBP1A 973/4885MEN1 4822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.